Appointment booking for Dr. Madeleine Harbison, MD is currently not available.Dr. Madeleine Harbison, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Madeleine Harbison, MD (she/her) is a Pediatric Endocrinologist in New York, NY with over 18 years of experience. What is your opinion of Dr. Madeleine Harbison, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Madeleine Harbison, MD has received over $13,585 which includes payments from the following companies:
$5,121.93 from BioMarin Pharmaceutical Inc.
$3,676.08 from Ipsen Biopharmaceuticals, Inc
$1,829.86 from Alexion Pharmaceuticals, Inc.
$988.17 from Novo Nordisk Inc
$595.83 from Becton, Dickinson and Company
$535.40 from EMD Serono, Inc.
$204.06 from AbbVie, Inc.
$167.33 from Genentech USA, Inc.
$131.46 from Sandoz Inc.
$125.00 from Ultragenyx Pharmaceutical Inc.
$118.38 from Pfizer Inc.
$72.42 from LILLY USA, LLC
$19.47 from Aegerion Pharmaceuticals, Inc.
Payments received by Dr. Madeleine Harbison, MD were from the following categories:
$4,155.83 Consulting Fee
$4,109.00 Food and Beverage
$3,000.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!